vortioxetine hydrobromide

vortioxetine hydrobromide (VORTIOXETINE HYDROBROMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

VORTIOXETINE HYDROBROMIDE is a marketed brand name for vortioxetine hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

vortioxetine hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.